![](https://www.endotext.org/wp-content/uploads/adrenal/7/figure2a.gif)
Figure 2AProposed pharmacological treatment for subjects on GC treatment and/or GCOP; modified from the recent ACR guidelines [227]; AL: alendronate, RIS: risedronate, ZA: zoledronic acid, TER: teriparatide, Rx: treatment, mos: months, *: based on a single randomized clinical trial, **: based on consensus, ?: no consensus